Medicover Secures Oversubscribed €450 Million Revolving Credit Facility

Medicover AB ( ($SE:MCOV.B) ) has issued an announcement.

Medicover has secured a new €450 million syndicated revolving credit facility with a three-year maturity and two one-year extension options, replacing its previous €300 million facility agreed in 2022. The financing was oversubscribed and syndicated among nine banks, signalling strong lender confidence in Medicover’s growth trajectory and reinforcing its financial flexibility to support ongoing expansion and operations.

Nordea led the transaction as Coordinating Bookrunner, Mandated Lead Arranger, Documentation Agent and Facility Agent, with additional European banks participating as bookrunners and mandated lead arrangers. The enlarged and oversubscribed facility underlines Medicover’s solid standing in credit markets and is likely to strengthen its capacity to invest across key healthcare and diagnostic markets in Europe and India, benefiting stakeholders reliant on its services and growth.

The most recent analyst rating on ($SE:MCOV.B) stock is a Hold with a SEK265.00 price target. To see the full list of analyst forecasts on Medicover AB stock, see the SE:MCOV.B Stock Forecast page.

More about Medicover AB

Medicover is a leading international healthcare and diagnostic services provider founded in 1995, operating ambulatory clinics, hospitals, laboratories and blood-drawing points. The company’s largest markets are Poland, Germany, Romania and India, and in 2025 it generated revenue of €2,378 million with a workforce exceeding 49,000 employees.

Average Trading Volume: 107,658

Technical Sentiment Signal: Hold

Current Market Cap: SEK30.5B

Learn more about MCOV.B stock on TipRanks’ Stock Analysis page.